ALBIO — Biosynex SA Share News
0.000.00%
- €16.48m
- €68.79m
- €95.19m
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals
French and Benelux stocks-Factors to watch
Brief: Biosynex Proposes Merger With Theradiag
Brief: Qualigen Therapeutics Divests Fastpack Diagnostics Business
Brief: Biosynex's Unit Chembio Inc. Acquires Qualigen Inc.
French and Benelux stocks-Factors to watch
Brief: Biosynex H1 Revenue Down 70% Due To Drop In Covid Sales
Brief: Biosynex To Acquire All Shares Not Already Held In Delaware Company Procisedx
Brief: Biosynex Acquires "Eye Care" Activity From Innoxa Laboratories
French and Benelux stocks-Factors to watch
Brief: Biosynex FY Consolidated Net Result Group Share Down At Eur 15.6 Mln
Brief: Biosynex Extends Tender Offer For Shares Of Chembio Diagnostics
Brief: Biosynex Extends Tender Offer For Shares Of Chembio Diagnostics
Brief: Biosynex Extends Tender Offer Period On Shares Of Chembio Diagnostics
Brief: Biosynex Extends Tender Offer For Shares Of Chembio Diagnostics
French and Benelux stocks-Factors to watch